Immune response to cyclin B1 in hepatocellular carcinoma

Hepatology

Volumn 25, Issue 1, 1997, Pages 75-80

  Covini, Giovanni ^a,c   Chan, Edward K L ^a   Nishioka, Mikio ^b   Morshed, Syed Ahmed ^b   Reed, Steven I ^a   Tan, Eng M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c Istituto di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN;

ANTIBODY DETECTION; ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031021286     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510250114     Document Type: Article

References (57)

1. White JM, Holborow EJ. Smooth muscle antibody in malignant disease. Br Med J 1971;4:511-513.
2. Ablin RJ. Antibodies to lymphocytes in cancer. Lancet 1972;1:41-48.
3. Burnham TK. Antinuclear antibodies in patients with malignancies. Lancet 1972;2:436-440.
4. Klein G, Steiner M, Wiener M, Klein E. Human leukemia-associated antinuclear reactivity. Proc Natl Acad Sci U S A 1974;71:685-689.
5. Wasserman J, Glas Y, Blomgren H. Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clin Exp Immunol 1975; 19:417-422.
6. Hodson ME, Turner-Warwick M. Autoantibodies in patients with bronchial carcinoma. Thorax 1975;30:367-370.
7. Nelson DS. Autoantibodies in cancer patients. Pathology 1977;9:155-160.
8. Lamelin JP, de-The G, Revillard JP, Gabbiani G. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients. IARC Sci Publ 1978;523-536.
9. Thomas PJ, Kaur JS, Aitcheson CT, Robinson WA, Tan EM. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res 1983;43:1372-1380.
10. Schattner A, Shani A, Talpaz M, Bentwich Z. Rheumatoid factors in the sera of patients with gastrointestinal carcinoma. Cancer 1983;52:2156-2161.
11. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93-151.
12. Pollard KM, Chan EKL, Rubin RL, Tan EM. Autoantibodies and autoimmunity. In: Mayers RA, ed. Encyclopedia of Molecular Biology and Molecular Medicine. Weinheim: VCH, 1995:84-93.
13. Tan EM. Autoantibodies in pathology and cell biology. Cell 1991;67:841-842.
14. Diamond B, Katz JB, Paul E, Aranow C, Lustgarten D, Scharf MD. The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992;10:731-757.
15. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994;12:487-520.
16. Winter SF, Minna JD, Johnson BE, Takahasi T, Gazdar AR, Carbone DP. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res 1992;52:4168-4174.
17. Davidoff AM, Ingelhart JD, Marks JR. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci U S A 1992;89:3439-3441.
18. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Francesc Graus BS, Posner JB. Selection expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322:1844-1851.
19. Posner JB, Furneaux HM. In: Waksman BH, ed. Immunologic Mechanisms in Neurologic and Psychiatric Disease. New York: Raven, 1990:187-219.
20. Altermatt HJ, Rodriguez M, Scheithauer BW, Lennon V. Paraneoplastic anti-Purkinje and type I antineuronal nuclear antibodies bind selectively to central, peripheral and autonomical nervous system cells. Lab Invest 1991;65:412-420.
21. Thirkill CE, FitzGerald P, Sergott RC, Roth AM, Tyler NK, Keltner JL. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic nerve and cancer cells. N Engl J Med 1989;321:1589-1594.
22. Polans AS, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991;112:981-989.
23. Buckanovich RJ, Yang YYL, Darnell RB. The onconeural antigen Nova-1 is a neuron-specific RNA binding protein and its activity is inhibited by paraneoplastic antibodies. J Neuroscience 1996;16:1114-1122.
24. Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. HnRNP proteins and the biogenesis of mRNA. Ann Rev Biochem 1993;62:239-321.
25. King P, Levine T, Fremeau R, Keene JD. Mammalian homologs of Drosophila elav localized to a neuronal subset can bind in vitro to the 3′ UTR of mRNA encoding the Id transcriptional repressor. J Neurosci 1994;14: 1943-1952.
26. Campos AR, Grossman D, White K. Mutant alleles at the locus elav in Drosophila melanogaster lead to nervous system defects. A developmental genetic analysis. J Neurogenet 1985;2:197-218.
27. Jiminez F, Campos-Ortega JA. Genes in subdivision 1B of the Drosophila melanogaster X-chromosome and their influence on neural development. J Neurogenet 1987;4:179-200.
28. Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992;140:859-870.
29. Imai H, Nakano Y, Kiyosawa K, Tan EM. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993;71:25-36.
30. Imai H, Chan EKL, Kiyosawa K, Fu X-D, Tan EM. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest 1993;92:2419-2426.
31. Hunter T, Pines J. Aberrant expression of cyclins maybe intimately associated with the neoplastic process. Cell 1991;66:1071-1074.
32. Keyomarsi K, Pardee AB. Abundant cyclin over express ion and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 1993;90:1112-1116.
33. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266: 1821-1828.
34. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A 1994;91: 709-713.
35. Bates S, Peters G. Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 1995;6:73-82.
36. Strauss M, Lukas J, Barter J. Unrestricted cell cycling and cancer. Nat Med 1995;1:1245-1246.
37. Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB. Amplification and over expression of cyclin D1 human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:1010-1016.
38. Gong J, Ardett B, Traganos F, Darzynkiewicz Z. Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. Cancer Res 1994;54:4285-4288.
39. Jares J, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA over expression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-4817.
40. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Fukuwara M, Amenomori M, et al. Amplification and over express ion of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994;54:3107-3110.
41. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
42. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Bahn A. Over expression of cyclin D1 correlates with recurrence in a group of fortyseven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-978.
43. Landberg G, Tan EM, Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exper Cell Res 1990;187:111-118.
44. Dulic V, Drullinger LF, Lees E, Reed SE, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 1993;90:11034-11038.
45. Dulic V, Lees E, Reed SE. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 1992;257:1958-1961.
46. McGowan CH, Russell P. Human Wee 1 kinease inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 1993;12:75-85.
47. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990; 186:60-89.
48. Chan EKL, Pollard KM. Autoantibodies to ribonucleoprotein particles by immunoblotting. In: Rose, NR, de Macario EC, Fahey JL, Friedman H, Penn GM, eds. Manual of Clinical Laboratory Immunology. Washington, D.C.: American Society of Microbiology, 1992:755-761.
49. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophase T4. Nature 1970;227:680-685.
50. Resnitzky D, Hengst L, Reed SE. Cyclin A-associated kinase is rate limiting for entrance into S phase and is negatively regulated in G1 by p27kipl. Mol Cell Biol 1995;15:4347-4352.
51. Covini G, Chan EKL, Colombo M, Tan EM. Comparison of protocols for depleting anti-E. coli antibody in immunoblotting of recombinant antigens. J Immunol Methods 1996;190:143-145.
52. Olmsted JB. Affinity purification of antibodies from diazotized paper blots of heterogeneous protein samples. J Biol Chem 1981;256:11955-11957.
53. Pines J, Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol 1991;115:1-17.
54. Gong J, Traganos F, Darzynkiewicz Z. Simultaneous analysis of cell cyclin kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. Cancer Res 1993;53:5095-5099.
55. Sherwood SW, Rush DF, Kung AL, Schmidke RT. Cyclin B1 expression in HeLa cells studied by flow cytometry. Exp Cell Res 1994;211:275-281.
56. Bravo R, MacDonald-Bravo H. Existence of two populations of cyclin/ PCNA during the cell cycle: association with DNA replication sites. J Cell Biol 1987;105:1549-1554.
57. Barber LD, Parham P. The essence of epitopes. J Exp Med 1994;180:1191-1194.